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Spinal cord ischemia after TEVAR in patients with
abdominal aortic aneurysms
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Objective: To examine the incidence of and the anatomic factors that may contribute to spinal cord ischemia (SCI) in
patients with a history of abdominal aortic aneurysms (AAA) after thoracic endovascular aortic repair (TEVAR).
Methods: The medical records, computed tomography (CT) angiograms, and a prospectively maintained clinical database
of all TEVAR patients at a single institution between 2000 and 2007 were reviewed. Select preoperative demographics,
thoracoabdominal aortoiliac anatomy, intraoperative procedural variables, and postoperative outcomes were examined.
Univariate and multivariate analyses were performed and odds ratio estimates were reported with 95% confidence
intervals.
Results:Of the 261 patients who underwent TEVAR, 27 developed SCI (10%). Thirteen (48%) of these 27 patients were
completely reversed with spinal drainage, and 14 (52%) were permanent. Patients with SCI tended to be older (P .006),
male (P  .049), and required more emergent procedures (P  .051) performed under general anesthesia (P  .004).
Interestingly, while prior AAA repair (50/261, 19%) alone was not associated with SCI (P  .44), a history of either
repaired or unrepaired AAA (101/261, 39%) was a predictor of SCI on multivariate analysis (odds ratio [OR]  4.35
[1.43, 14.3], P  .10), independent of thoracic aortic coverage (P  .001) and lumbar artery patency (P  .008), both
of which were also associated with SCI.
Conclusion: Although the causes of SCI after TEVAR are multifactorial, abdominal aortic anatomy appears to be
associated with development of this complication. Patients with either prior AAA repair or those with unrepaired AAA
appear to be at increased risk for SCI. (J Vasc Surg 2009;49:302-7.)Spinal cord ischemia (SCI) is a devastating complica-
tion in patients undergoing surgical or endovascular repair
of the thoracic aorta. The incidence of SCI has been re-
ported to be between 0-14% for patients undergoing tho-
racic endovascular aortic repair (TEVAR).1-11 Periopera-
tive risk factors contributing to this complication have been
reported to include length of aortic coverage,8,10,12 prior
abdominal aortic aneurysm (AAA) repair,1,5,7 hypoten-
sion,3,13,14 and left subclavian artery coverage.15-18 Al-
though the putative mechanism of loss of lumbar collateral
perfusion in those who had prior aortic repairs appears
reasonable, occurrence of SCI in this subset of patients has
not been consistent. In this study, we examined the inci-
dence of and the anatomic factors that may contribute to
SCI in patients with a history of AAAs after TEVAR.
METHODS
Between September 2000 and September 2007, 261
TEVARs were performed at a single tertiary-care university
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302medical center. We retrospectively reviewed a prospectively
maintained thoracic endovascular database, as well as the
medical records and imaging studies of all patients who
underwent stent graft repair of their thoracic aorta. Preop-
erative demographics and thoracoabdominal aortoiliac
anatomy, intraoperative procedure-related measures, de-
vice usage, and postoperative outcomes were assessed. This
study had been approved by the Institutional Review
Board.
All patients underwent preoperative and postoperative
computed tomographic angiography (CTA) (Toshiba Aquil-
ion, Tustin, Calif, 16-64 multislice detectors depending on
the year of the study) using a timed-bolus, intravenous con-
trast technique acquired at 2-3 mm collimations. The dataset
was then reconstructed andpost-processedusing theAquarius
Workstation (TeraRecon, San Mateo, Calif). This was used
to assess preoperative aortoiliac morphology, dimensions,
branch vessel patency, and postoperative aortic coverage.
An AAAwas defined using amaximum transverse aortic
diameter of 30 mm. Although this definition may seem
arbitrary, the 30-mm threshold has numerous precedents
in the published literature and has been more commonly
used than the 1.5X diameter of adjacent “normal” artery
criterion.19-23 Furthermore, all of the aneurysms showed
focal dilation of the aorta and did not simply represent
ectasia or arteriomegaly.
SCI was defined as any new lower extremity motor
and/or sensory deficit. It was considered “transient” (vs
“permanent”) when a clear deficit was documented and
then completely reversed to the patient’s baseline func-
tional status. Even when a patient’s symptoms had im-
proved but his or her functional status was not restored to
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manent”.
Prophylactic spinal drainage was primarily based on
operator preference and no clear protocol was followed
during the study period. The only exceptions to this prac-
tice included patients who had focal pathologies, such as
penetrating ulcers or traumatic transections, and required
10 cm of thoracic coverage or had coagulopathy (inter-
national normalized ratio, [INR] 1.3) that could not be
corrected in a timely manner precluding safe placement of a
spinal catheter.
All patients were admitted postoperatively to the Car-
diac Intensive Care Unit, where neurologic exams were
performed hourly. Upon detection of symptoms, the blood
pressure was elevated to a systolic pressure of160mmHg
(mean arterial pressure of 100 mm Hg) with vasopres-
sors, and a spinal catheter was promptly (2 hours of
symptoms) placed by a qualified cardiac anesthesiologist (in
those patients who were not drained preoperatively). The
spinal drainage catheter was placed at 10 cm above the level
of the heart and adjusted higher or lower depending on the
amount of spinal fluid drainage and therapeutic effect. The
catheter was left in place for 72 hours. After reversal of SCI,
the catheter was clamped for another 24 hours in case the
symptoms returned, and then removed.
Continuous data were analyzed using a two-tailed t test
and categorical variables using Fisher’s exact test, with P
.05 considered statistically significant. Univariate and mul-
tivariate logistic regression models were constructed using
a set of 20 potential predictors: age, gender, BMI (body
mass index), American Society of Anesthesiologists (ASA)
classification, type, maximum diameter, and length of tho-
racic aortic pathology being treated, endograft type, history
of AAA repair, lumbar and hypogastric artery patency, left
subclavian artery (LSA) coverage, urgency of the proce-
dure, preoperative spinal drainage, anesthetic technique,
iliac conduit, thoracic aortic length (from left common
carotid artery to celiac artery) and endograft coverage,
duration of procedure, and blood loss. Odds ratio estimates
were reported with 95% confidence intervals.
RESULTS
Of the 261 patients who underwent TEVAR, 67%
(176/261) were men and the mean age was 66.2  15.2
years with a BMI of 26.8 5.5 kg/m2. The majority of the
patients were designated as ASA IV (160/261, 61%) and
had either degenerative aneurysms (52%, 136/261) or
dissections (21%, 55/261). The TAG endograft (W. L.
Gore, Flagstaff, Ariz) was the only commercially-available
thoracic aortic device during the study period and, there-
fore, 78% (204/261) patients were repaired using this
system, with the balance comprised of investigational de-
vices. Eighty-eight (34%) of the 261 procedures were per-
formed emergently for acute or symptomatic conditions,
such as ruptures or complicated dissections, and general
anesthesia was used in 69% (179/261) cases. Iliac conduits
were required in 19% (50/261) of cases and only 12%
(31/261) had prophylactic spinal drainage. The mean du-ration of the procedures was 113  67 minutes and blood
loss 308  365 mL. Overall, there were 33 intraoperative
complications in 27 patients for an event rate of 10.3% and
1.2 events/person (Table I). Postoperatively, there were
177 30-day or in-hospital complications in 92 patients for
an overall rate of 35% and 1.9 events/patient. Early mor-
tality was 6.5% (17/261) (Table II).
SCI occurred in 10.3% (27/261) of cases. Thirteen
(48.1%) were completely reversed with spinal drainage, and
14 (51.9%) were permanent. Patients who developed SCI
were older (74  9 vs 65  16 years, P  .006), had a
higher proportion of men (85% vs 65%, P  .049), lower
BMI (23.6 vs 27.0 kg/m2, P  .003), more emergent
procedures (52% vs 32%, P  .051) performed under
general anesthesia (93% vs 66%, P  .004), and longer
operating times (143 79 vs 110 65minutes, P .014)
than those who did not have SCI. However, there were no
significant differences in the ASA class, endograft type,
intraoperative blood loss, incidence of LSA coverage, use of
iliac conduits, or prophylactic spinal drainage between the
two cohorts (Table III).
The mean length of the thoracic aorta for the entire
group was 289  39 mm. Patients with SCI had a larger
maximum thoracic aortic diameter (P  .014), longer
thoracic aortic length (P  .036), and higher fractional
Table I. Intraoperative complications
Complication N (%)
Vascular access-related 18 (6.9)
Endograft-related 2 (0.8)
Stroke 6 (2.3)
Cardiac arrest 2 (0.8)
Aortic dissection 1 (0.4)
Other1 4 (1.5)
1-unplanned LSA occlusion (1), bowel injury during retroperitoneal expo-
sure (1), thromboembolism (1), mesenteric ischemia (1).
Table II. Postoperative (in-hospital or 30-day)
complications
Complication N (%)
Wound1 7 (1.5)
Bleeding2 11 (4.2)
Cardiac3 9 (3.4)
Pulmonary4 25 (9.6)
Neurologic5 43 (16.5)
Ischemic6 18 (6.9)
Gastrointestinal7 9 (3.4)
Renal8 14 (5.4)
Death 17 (6.5)
Other9 24 (9.2)
1-access site infections and incisional dehiscence; 2-pseudoaneurysms and
hematomas; 3-myocardial infarction and arrhythmia; 4-pneumonia and
prolonged respiratory insufficiency; 5-SCI, strokes, or peripheral neuropa-
thy; 6-peripheral ischemia from any cause; 7-ileus, bleeding, or colitis;
8-decreased estimated glomerular filtration rate and need for dialysis;
9-infectious, hematologic, vascular, or device-related events.endograft coverage of their thoracic aorta (P .0001) than
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thoracic procedures, 39% (101/261) of the patients had
either a repaired (51/101) or unrepaired (50/100) AAA.
The mean size of the unrepaired AAA in the SCI and
no-SCI groups were similar (38.9  9.4 vs 41.2  10.4
mm, P  .27). On univariate analysis, while a prior AAA
repair alone was not associated with SCI (odds ratio
[OR]  1.56 [0.63, 3.85], P  .34), a history of either
repaired or unrepaired AAA was strongly predictive of SCI
(OR  3.57 [1.56, 8.33], P  .003) (Table IV).
Axial images from 254 preoperative CTA were serially
reviewed from the celiac artery to the aortic bifurcation and
the number of patent lumbar and hypogastric arteries
counted. Seven scans were unavailable for analysis. The
mean number of patent lumbar arteries was significantly
lower in the SCI group compared to the no-SCI group
(P  .008), while hypogastric artery patency was similar
(Fig). Univariate analysis showed that each additional
patent lumbar artery conferred approximately a 17% reduc-
tion in the risk of SCI.
Multivariate logistic regression analysis was performed
to eliminate potential confounders. Again, a history of
either repaired or unrepaired AAA was highly indepen-
dently predictive of SCI (OR  4.35 [1.43, 14.3], P 
.10). Other variables which remained independently asso-
ciated with SCI included extent of thoracic aortic coverage
(OR 2.0 [1.3, 3.1], P .002, for every 10% or2.9 cm
incremental coverage) and general anesthesia (OR  7.7
[1.6, 37], P  .012).
DISCUSSION
Endovascular repair has become a minimally-invasive
alternative to the treatment of a variety of thoracic aortic
Table III. Univariate analysis
Variable No SCI (n  234) SCI (n  27) P
Age (years) 65.2  15.6 73.8  8.8 .006
Males 153 (65%) 23 (85%) .049
BMI (kg/m2) 27.0  5.1 23.6  8.6 .003
ASA IV 140 (60%) 20 (74%) .21
Aortic pathology .24
TAA 122 (52%) 14 (52%)
Dissection 46 (20%) 9 (33%)
Penetrating ulcer 37 (16%) 4 (15%)
Traumatic transection 15 (6%) 0 (0%)
Other 14 (6%) 0 (0%)
Endograft (TAG) 181 (77%) 23 (85%) .46
Patent LSA 143 (61%) 18 (67%) .68
Emergent procedure 74 (32%) 14 (52%) .051
Prophyl spinal drain 29 (13%) 2 (7%) .75
General anesthesia 154 (66%) 25 (93%) .004
Iliac conduit 44 (19%) 6 (22%) .61
Proc duration
(minutes) 110  65 143  79 .014
Blood loss (mL) 304  380 339  196 .64
SCI, Spinal cord ischemia; BMI, body mass index;ASA, American Society of
Anesthesiologists; TAA, thoracic aortic aneurysm; LSA, left subclavian
artery.pathologies with decreased perioperative mortality, respira-tory failure, renal insufficiency, and hospital stay compared
to open repair.24-26 Spinal cord ischemia after endovascular
repair is a devastating complication whose occurrence has
been difficult to predict preoperatively. One of the risk
factors that has been previously reported to be associated
with SCI has been prior AAA repair.1,5,7
In this study, we showed that not prior AAA repair, per
se, but rather a history of either repaired or unrepaired AAA
was associated with SCI. Our finding is consistent with the
recent report by Baril et al1 who also noted an increased
incidence of SCI in patients with concomitant AAA or
previously repaired AAA (14.3%) vs patients with no AAA
(1.0%). In our study, the incidence of SCI in patients with
either repaired or unrepaired AAAwas 18% (18/101) vs 6%
(9/160) in patients without any history of AAA (P .003).
Unlike in aortoiliac occlusive disease where many of the
lumbar arteries are frequently patent and enlarged serving
as important collateral supply to the pelvis, in patients with
AAA one or more lumbar arteries are occluded. Indeed, the
mean number of lumbar arteries in those with a history of
AAA (repaired or unrepaired) was significantly less than in
those without an AAA (4.5 3.0 vs 7.6 1.3, P .0001),
and 78% of the former cohort had at least two occluded
lumbar arteries. On the other hand, as shown by the
multivariate analysis, decreased lumbar artery perfusion
alone does not account for the pathophysiology of SCI in
patients with unrepaired AAA.
Above and beyond its association with AAA, patients
with SCI had a decreased number of patent lumbar arteries
compared to those who did not develop SCI. The incidence
of SCI was 22% (13/59) if there were less than five patent
lumbar arteries compared to 6.7% (13/195) in those who
had five ormore (P .002). A limitation of our CTA-based
analysis is that identification of patent arteries is obviously
dependent on the technique and quality of the image
acquisition. The possibility of inadequate contrast delivery
to a lumbar artery resulting in the appearance of an oc-
cluded vessel cannot be ruled out, as well as the failure to
detect smaller lumbar vessels (1 mm) and differentiation
between direct vs collateral perfusion.
Finally, despite numerous prior publications suggesting
an association between LSA coverage and SCI,15-18,27 nei-
ther our study nor the one by Amabile et al28 found such a
correlation. In the current series, SCI occurred in 11%
(18/161) of those with and in 9% (9/100) of those with-
out a patent LSA (P  .68). Despite its apparent anatomic
basis, the actual contribution to overall spinal cord perfu-
sion by one or both vertebral arteries via the anterior spinal
artery is difficult to determine, and we do not believe
justifies prophylactic revascularization in every case of LSA
coverage. Currently, the main indications in our practice
for preoperative subclavian artery bypass include a domi-
nant left vertebral artery with a diminutive right vertebral
artery and/or a patent left internal mammary artery
(LIMA) graft to the left anterior descending (LAD) coro-
nary artery. To this end, CTA imaging of the intracranial
circulation is routinely performed as part of our preopera-
tive imaging protocol. The incidence of symptomatic left
amete
aneur
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(44%) cases that had LSA coverage, 7 had prophylactic
preoperative revascularizations and only 2 (1.7%) required
LSA bypass for upper extremity ischemia.
CONCLUSION
Symptoms of SCI can occur in up to 10% of those
undergoing TEVAR, only about half of which are perma-
nent. Patients with a history of either repaired or unrepaired
AAA face over four times increased risk of developing SCI
as compared to those without an AAA and is independent
of the length of thoracic aorta covered. Prophylactic mea-
sures for spinal cord protection should be considered in the
subset of individuals with this preoperative risk factor.
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Table IV. Aortoiliac anatomy and SCI
Variable No SCI (n  234)
AAA (un/repaired) 83 (35%)
History of repaired AAA 43 (18%)
No. patent lumbar arteries 6.57  2.58
No. patent hypogastric arteries 1.92  0.32
Diameter of thoracic pathology (mm) 60.0  15.3
Length of thoracic pathology (mm) 123.5  89.4
Length of thoracic aorta 282.7  38.8
Covered thoracic aorta (% total) 66.1  23.8
1-for each additional patent lumbar artery; 2-for every 10 mm increase in di
SCI, Spinal cord ischemia; CI, confidence interval; AAA, abdominal aortic
Fig. Histogram of patent lumbar arteries in the SCI and no SCI
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Spinal cord ischemia (SCI) is clearly one of the more devastat-
ing complications after the repair of any thoracic pathology by any
means. The multifactorial etiology of the complication has so far
resulted in a variety of management strategies that have failed to
garner uniform adoption. Endografting of thoracic aneurysms
(TEVAR) was greeted with the expectation that this feared out-
come would be diminished by avoiding aortic clamping and pro-
longed ischemia of the cord. This optimism appears well justified
by most early published results, as SCI seems to occur in 5% of
cases and mostly in aneurysmal pathology of the thoracic aorta and
less so with dissection or transection.1-4
In an effort to further limit the occurrence of SCI, a diligent
search for predisposing risk factors has so far resulted in a myriad of
associations with little consensus about the relative importance of
any. Notable suspects include length of thoracic aortic coverage,
left subclavian artery exclusion without reconstruction, elimination
of intercostal blood supply, especially the artery of Adamkiewicz,
poor lumbar and internal iliac artery collaterals, intraoperative
hypotension, conduit use for access, and underlying aneurysmal
pathology. The presence of a concurrent or remotely repaired
abdominal aortic aneurysm (AAA) has also been repeatedly impli-
cated, with only sparse supporting evidence.
This issue of the Journal of Vascular Surgery brings the reader
two reports focusing on the risk of SCI after TEVAR in patients
with AAA. The reports differ in methodology, results, patient
population, and extent of use of prophylactic spinal drainage, yet
are remarkably similar in the estimated risk of SCI in patients with
prior AAA repair: 12.5% in a multicenter study limited to thoracic
aneurysms and 14% in a single-center series with a potpourri of
diagnoses. The incidence is notably the same as that reported in a
smaller series by Baril in 2006.5
Despite the inherent methodologic problems of all these
retrospective analyses, and other negative reports, the evidence is
mounting that SCI risk is elevated after TEVAR in patients with
remote aneurysm repair. The incidence of SCI seems to be signif-
icantly higher in this patient subgroup irrespective of other risk
factors that may exist. The SCI hazard ratio in patients with AAA
seems to range between 4 and 7.
The report from the University of Florida by Martin indicatesuntreated concurrent AAA as small as 3.0 cm in diameter, a size
rarely considered an aneurysm in most clinical settings. This find-
ing adds another dimension to the association of SCI with any
current aneurysmal pathology of the abdominal aorta and clearly
constitutes a cause for concern in the preoperative risk benefit
assessment before TEVAR.
The rest of the information provided by these two studies is
somewhat disparate due to different methodology and inclusion
criteria. The multicenter study by Schlosser reports a somewhat
enviable SCI rate of only 1.7% after TEVAR for thoracic aneurysms
in the absence of prior AAA repair. In the absence of any abdominal
aortic pathology, Martin still reports a rate of 5.6% in a more
diverse group including patients with dissections, transections, and
other pathologies that would have been expected to lower the
incidence of this complication.
An SCI rate of 10% in the entire TEVAR series from a
group with a large experience such as the University of Florida
is quite sobering, pointing out that we have a long way to go
before understanding all the factors that may influence the
development of this debilitating complication. The contribu-
tions of emergency interventions as well as hybrid procedures to
this elevated risk is not entirely clear from the data presented.
Prospective focused collection of data may be required before
providing guidelines for the proper selection of patients and con-
duct of the operation to minimize these unfortunate outcomes.
In the meantime these two studies provide a strong reminder
that caution should be exercised when offering TEVAR to a large
group of patients who present with remote or concurrent AAA. A
careful analysis of the risk/benefit ratio under these circumstances
should lead us to only offer TEVAR to patients with a higher risk
profile of the underlying pathology, raising the size threshold for
intervention on aneurysmal disease of the thoracic aorta.
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